Brief: Crescent Biopharma - May Offer And Sell Up To $500 Million Of Securities - SEC Filing
01/07/2026 21:25
BRIEF-Crescent Biopharma - May Offer And Sell Up To $500 Million Of Securities - SEC Filing July 1 (Reuters) - Crescent Biopharma Inc CBIO.O:
CRESCENT BIOPHARMA - MAY OFFER AND SELL UP TO $500 MILLION OF SECURITIES - SEC FILING
Source text: [ID:n0001628280-26-046544]
Further company coverage: CBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering